The Challenges for EU User Testing Policies for Patient Information Leaflets.

ABSTRACT: Patient information leaflets (PILs) are essential tools in healthcare, providing crucial information about medication use. In the European Union, the European Medicines Agency (EMA) oversees the regulation and standardisation of PILs to ensure their readability and accessibility. However, challenges persist in ensuring these documents are comprehensible and user-friendly. This study employs a qualitative analytical approach, reviewing existing literature and regulatory documents to identify gaps in the EU user testing policies for PILs. It focuses on the diversity of participant samples, the independence of the testing process, and the robustness of user testing protocols. Findings indicate that current user testing practices often lack diversity and may be biased when pharmaceutical compa

SUBMITTER: Pelizzari N 

PROVIDER: S-EPMC11507276 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature